维普中文期刊产品整合服务
68篇 您的检索式:作者名="Fogarty S"
    题名 作者 年代 出处 被引量
1Knowledge spillovers and patent citations: Evidence from a survey of innovators显示文摘Jaffe Adam B Manuel Trajtenberg and Michael S Fogarty 2000Industrial Technology and Productivity2000,90,2:1
2Stereotactic breast biopsy:improved tissue harvesting with the Mammotome显示文摘Burbank F Parker S H Fogarty T J 1996The American Surgeon1996,62,9:1
3Job Satisfaction anti Retention of Health-care Providers in Afghanistan and Malawi显示文摘Fogarty L Kim Y M Juon H S 2014Hum Resour Health2014,,:1
4Evidence from patents and patent citations on the impact of NASA and other federal labs on commercial innovation显示文摘Jaffe A B Fogarty M S Banks B A 1998Journal of Industrial Economics1998,46,2:1
5Stereotaetie breast biopsy :improved tissue harvesting with the Mammotome 显示文摘Burbank F Parker S H Fogarty T J 1996Am Surg1996,62,9:1
6The high mal- tose-forming a-amylase of Saccharomonospora viridis: mechanisms of action显示文摘FOGARTY W M COLLINS B S DOYLE E M 1993J Ind Mierobiol1993,11,3:1
7Sediment concentration changes inrunoff pathways from a forest road network and the resultant spatialpattern of catchment connectivity显示文摘Croke J Mockler S Fogarty P 2005Geomorphology2005,68,34:1
8The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease 显示文摘RENNARD S I FOGARTY C KELSEN S 2007Am J Respir Cril Care Med2007,175,92:1
9Predicting human interruptibility with sensors显示文摘Fogarty J Hudson S E Atkeson C G 2005ACM Trans Com- put-Hum Interact(TOCHI)2005,12,1:1
10The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease显示文摘Rennard SI Fogarty C Kelsen S 0,,:1
11Exploring downsizing: a case study on the use of accounting information 显示文摘Radcliffe V S Campbell D R Fogarty T J 2001Journal of management Accounting Research2001,13,:1
12The safety and efficacy of infliximab in moderate-to-severe chronic obstructive pulmonary disease 显示文摘Rennard SI Fogarty C Kelsen S 2007Am J Respir Crit Care Med2007,175,9:1
13Development of protein kinase activators :AMPK as a target in metabolic disorders and cancer 显示文摘Fogarty S Hardie DG 2010BuicghimBiophys Acta2010,1804,3:1
14Efficacy of moxifloxacin for treatment of penicillin-, macrolide- and mtxltidrug-resistant Streptococcus pneumoniae in community-acquired pneumonia 显示文摘Fogarty C Torres A Choudhri S 2005Int J Clin Pract2005,59,:1
15Evidence from patents and patent citations on the impact of NASA and other federal labs on commercial innovation 显示文摘JAFFE A B FOGARTY M S BANKS B A 1998The journal of industrial economics1998,46,2:1
16Evidence from patents and patent citations on the impact of NASA and other federal labs on commercial innovation 显示文摘JAFFE A B FOGARTY M S BANKS B A 1998Journal Of Industrial Ecnomics1998,,:1
17The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease显示文摘Rennard SI Fogarty C Kelsen S 2007Am J Respir Crit Care Med2007,175,9:1
18Development of protein kinaseactivators:AMPK as a target in metabolic disorders and cancer显示文摘Fogarty S Hardie DG 2010BiochimBiophys Acta2010,1804,3:1
19Longterm changes in the Georges Bank food web: trends in stable isotopic compositions of fish scales 显示文摘Wainfight S C Fogarty M J Green field R C 1993Mar Bio11993,115,:1
20Abundance and characteristics of the recreational water quality indicator bacteria Escherichia coil and enterococci in gull faeces显示文摘Fogarty L R Haack S K Wolcott M J 2003J Appl Microbiol2003,94,5:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费